# FUSE Creatine — Daily Report

**Date**: 2026-01-28

---

## Task Queue

| Status | Count |
|--------|-------|
| Pending | 0 |
| Active | 0 |
| Completed Today | 1 |

## Team Status

### Developers (DEV)

**State**: Website live at fuse-creatine.vercel.app. Agent orchestration system functional but being refactored to CLI-first architecture. CEO Dashboard needs queue integration.

**Top Priority**: **HIGH**: Complete CLI tool core commands (status, queue, task)

### Product (PRD)

**State**: FUSE Creatine is in pre-launch phase. Core product concept validated. Formulation approach identified (micro-encapsulation). Building waitlist while finalizing technical and regulatory requirements.

**Blockers**: **Formulation timeline**: Dependent on R&D's FTO analysis and supplier selection; **Pricing strategy**: Needs input from Sales on market positioning

**Top Priority**: **HIGH**: Finalize launch criteria checklist

### Marketing (MKT)

**State**: Pre-launch phase. Primary focus is waitlist growth and brand awareness. Website live with waitlist signup modal. No paid campaigns active yet.

**Blockers**: **Budget allocation**: Need CEO approval for paid campaigns; **Claims review**: Some website claims pending Legal review

**Top Priority**: **HIGH**: Grow waitlist to 500 signups

### Sales (SLS)

**State**: Pre-launch. No active sales yet. Focus is on pricing strategy and identifying B2B partnership opportunities for launch.

**Blockers**: **No product to sell yet**: Dependent on R&D formulation; **Pricing approval**: Needs CEO sign-off

**Top Priority**: **HIGH**: Finalize D2C pricing strategy

### Branding (BRD)

**State**: Core brand identity established. Website design live. Design system needs documentation. Packaging design not yet started.

**Blockers**: **Packaging**: Need product dimensions from R&D; **Asset library**: Needs organizing and documentation

**Top Priority**: **HIGH**: Document design system (colors, typography, spacing)

### Legal (LGL)

**State**: Core compliance framework established. Permitted health claims documented. Patent landscape analyzed — AnaBio holds key micro-encapsulation patents, alternative methods identified.

**Blockers**: **FTO Analysis**: Need to commission from patent attorney (£10-25k); **Trademark Search**: Pending professional search

**Top Priority**: **CRITICAL**: Commission FTO analysis before formulation investment

### Comms (COM)

**State**: Brand voice defined. No active social media presence yet. Focus is on messaging framework and launch communications planning.

**Blockers**: **Social accounts**: Not yet created; **Press contacts**: Media list needs building

**Top Priority**: **HIGH**: Complete messaging matrix

### Digital Content (DCT)

**State**: Website copy complete. No blog or email sequences yet. Focus is on building content pipeline for launch.

**Blockers**: **Email platform**: Need to select and set up (Mailchimp, ConvertKit, etc.); **Blog setup**: Need Developers to add blog section to site

**Top Priority**: **HIGH**: Write waitlist email nurture sequence (5 emails)

### R&D (R&D)

**State**: Scientific feasibility validated. Creatine stability in hot coffee confirmed (<5% degradation). Patent landscape analyzed — AnaBio has key patents, but alternative encapsulation methods available. Need FTO analysis before major formulation investment.

**Blockers**: **FTO Analysis**: CRITICAL — Cannot proceed with formulation investment until Legal completes Freedom-to-Operate analysis (risk: patent infringement); **Supplier samples**: Need to request samples from shortlisted suppliers

**Top Priority**: **CRITICAL**: Wait for FTO analysis before major investment

